GlassScriptPhysician profile
Hani R Douedi
NPI 1922073949
$71,841.90
in general payments reported to CMS, 2019-2025
44 companies · $1,897 in 2025
The $1,897 reported for 2025 was more than what 83% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $8,623 · 2021: $13K · 2022: $16K · 2023: $8,924 · 2024: $9,328 · 2025: $1,897.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $12K · Food and Beverage: $7,751.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $12,398.00 |
| Food and Beverage | $7,750.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $57,057.92 | 2019-2024 | Xarelto |
| Abbott Laboratories | $3,758.89 | 2019-2025 | Aveir, Amplatzer Amulet, Jot Dx |
| E.R. Squibb & Sons, L.L.C. | $2,325.44 | 2019-2025 | Camzyos, Eliquis |
| Astrazeneca Pharmaceuticals LP | $1,411.30 | 2019-2025 | Farxiga, Wainua, Brilinta |
| Boston Scientific Corporation | $1,354.00 | 2019-2025 | Bodyguardian, S-Icd System Magnet, Watchman Flx |
| Boehringer Ingelheim Pharmaceuticals, INC. | $952.40 | 2019-2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $828.39 | 2019-2025 | |
| Pfizer INC. | $465.97 | 2019-2025 | |
| Esperion Therapeutics, INC. | $452.49 | 2020-2025 | Nexletol |
| Amgen INC. | $399.08 | 2019-2025 | Repatha |
| Novo Nordisk INC | $214.90 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Merck Sharp & Dohme LLC | $196.92 | 2021-2024 | Verquvo |
| Shockwave Medical, INC | $171.05 | 2021 | |
| Acist Medical Systems, INC. | $165.42 | 2022 | |
| Amarin Pharma, INC. | $163.60 | 2019-2022 |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $160.11 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $156.65 | 2019-2023 | Lifevest |
| Scpharmaceuticals INC. | $146.61 | 2024-2025 | |
| Medtronic, INC. | $146.52 | 2021-2025 | Symplicity G3 |
| Kowa Pharmaceuticals America, INC. | $135.60 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $133.02 | 2019-2024 | |
| Atricure, INC. | $114.18 | 2020 | |
| Catheter Precision INC. | $103.00 | 2023 | |
| Stereotaxis INC | $91.46 | 2023 | Niobe |
| Azurity Pharmaceuticals, INC. | $62.66 | 2023 | Edarbi |
| Kiniksa Pharmaceuticals, LTD. | $57.72 | 2022-2023 | Arcalyst |
| Regeneron Healthcare Solutions, INC. | $56.70 | 2019-2024 | Evkeeza |
| Bardy Diagnostics, INC. | $55.00 | 2020-2021 | |
| Cvrx, INC. | $47.35 | 2023-2024 | Barostim Neo System |
| Gilead Sciences, INC. | $44.27 | 2019 | |
| Heartflow, INC. | $42.23 | 2024-2025 | |
| Impulse Dynamics (USA) INC. | $41.03 | 2024 | Optimizer |
| Arbor Pharmaceuticals, INC. | $40.62 | 2020-2022 | |
| Astellas Pharma US INC | $39.62 | 2020-2021 | |
| Daiichi Sankyo INC. | $37.02 | 2023 | Injectafer |
| Baxter Healthcare | $32.97 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Edwards Lifesciences Corporation | $32.67 | 2022-2025 | Sapien 3 Ultra Resilia |
| Bayer Healthcare Pharmaceuticals INC. | $31.25 | 2022-2025 | |
| Preventice Services, LLC | $29.87 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $27.54 | 2024 | |
| Tactile Systems Technology INC | $18.65 | 2020 | |
| Alnylam Pharmaceuticals INC. | $14.05 | 2024 | Amvuttra |
| Medicure Pharma INC. | $13.02 | 2021 | |
| Cashflow Solutions, LLC | $12.74 | 2024 | Pcd-51 731a (US) - White, Pcd-52 737a (US) White, Lympha Press Optimal Plus(US) Bt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hani Douedi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.